Gerresheimer (GXI) Stock Price, News & Analysis

Company Overview

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Key Stats

• Today's Range: €49.56 to €51.90
• 50-Day Range: €50.80 to €81.50
• 52-Week Range: €81.35 to €111.20
• Volume: 309,705 shs
• Average Volume: 140,925 shs
• Market Capitalization: $1.78 billion
• P/E Ratio: 15.53
• Dividend Yield: 2.41%
• Price Target: N/A
• Consensus Rating: N/A

GXI Stock Analysis - Frequently Asked Questions

How have GXI shares performed this year?

Gerresheimer's stock was trading at €71.00 at the beginning of 2025. Since then, GXI stock has decreased by 27.0% and is now trading at €51.85.
View the best growth stocks for 2025 here.

What other stocks do shareholders of Gerresheimer own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Gerresheimer investors own include Intel (INTC), Abbott Laboratories (ABT), AutoZone (AZO), Bank of America (BAC), Bayer Aktiengesellschaft (BAYN), Danaher (DHR) and Alcoa (AA).

Industry, Sector and Symbol

• Stock Exchange: ETR
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: ETR:GXI
• CIK: N/A
• Web: www.gerresheimer.com
• Phone: +49-211-618100
• Fax: N/A
• Employees: 11,947
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): €3.34
• Trailing P/E Ratio: 15.53
• Forward P/E Ratio: N/A
• P/E Growth: 0.82
• Net Income: $113.29 million
• Net Margins: 5.68%
• Pretax Margin: N/A
• Return on Equity: 7.89%
• Return on Assets: 3.97%

Debt

• Debt-to-Equity Ratio: 87.94
• Current Ratio: 0.80
• Quick Ratio: 0.40

Sales & Book Value

• Annual Sales: $1.99 billion
• Price / Sales: 0.89
• Cash Flow: €3.49 per share
• Price / Cash Flow: 14.85
• Book Value: €42.22 per share
• Price / Book: 1.23

Miscellaneous

• Outstanding Shares: 34,236,828
• Free Float: N/A
• Market Cap: $1.78 billion
• Optionable: Not Optionable
• Beta: 0.94